T 2168/11 (Alzheimer's disease beta amyloid peptide mouse model/ELAN ELI LILLY) of 24.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T216811.20150624
- Date of decision
- 24 June 2015
- Case number
- T 2168/11
- Petition for review of
- -
- Application number
- 94931891.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TRANSGENIC ANIMALS HARBORING APP ALLELE HAVING SWEDISH MUTATION
- Applicant name
- ELAN PHARMACEUTICALS, INC.
ELI LILLY AND COMPANY - Opponent name
- F. HOFFMANN-LA ROCHE & CO.
Aktiengesellschaft
GLAXO GROUP LIMITED
Bayer AG - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- "Main Request - inventive step (no)"
"Admissibility of first, second and third Auxiliary Requests into the appeal proceedings (no)" - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.